Indies Pharma Jamaica Limited has told the Jamaica Stock Exchange that the COVID-19 pandemic has had a negative impact on its revenue streams.
The company in a note said there has been disruption in its supply chain system which affected stock levels for certain key products.
Indies Pharma says to an extent, its operations were also negatively impacted on the Jamaican market front due to the limitations applied to its delivery schedules and limited number of working days.
However, a reasonable estimate of the impact cannot be made at this time.
The company says it is at an advanced stage of planning its production and supply chain channels so that it will remain self-sufficient and productive during its new fiscal year that started on November 1.